Abstract
Purpose
To retrospectively evaluate the ability of magnetic resonance imaging (MRI) to differentiate malignant from benign myometrial tumours.
Methods
Fifty-one women underwent MRI before surgery for evaluation of a solitary myometrial tumour. At histopathology, there were 25 uncertain or malignant mesenchymal tumours and 26 benign leiomyomas. Conventional morphological MRI criteria were recorded in addition to b 1,000 signal intensity and apparent diffusion coefficient (ADC). Odds ratios (OR) were calculated for each criterion. A multivariate analysis was performed to construct an interpretation model.
Results
The significant criteria for prediction of malignancy were high b 1,000 signal intensity (OR = +∞), intermediate T2-weighted signal intensity (OR = +∞), mean ADC (OR = 25.1), patient age (OR = 20.1), intra-tumoral haemorrhage (OR = 21.35), endometrial thickening (OR = 11), T2-weighted signal heterogeneity (OR = 10.2), menopausal status (OR = 9.7), heterogeneous enhancement (OR = 8) and non-myometrial origin on MRI (OR = 4.9). In the recursive partitioning model, using b 1,000 signal intensity, T2 signal intensity, mean ADC, and patient age, the model correctly classified benign and malignant tumours in 47 of the 51 cases (92.4 %).
Conclusion
We have developed an interpretation model usable in routine practice for myometrial tumours discovered at MRI including T2 signal, b 1,000 signal and ADC measurement.
Key Points
• MRI is widely used to differentiate benign from malignant myometrial tumours.
• By combining T2-weighted, b 1,000 and ADC features, MRI is 92.4 % accurate.
• DWI may limit misdiagnoses of uterine sarcoma as benign leiomyoma.
• Patient age is important when considering a solitary myometrial tumour.
Similar content being viewed by others
Explore related subjects
Discover the latest articles, news and stories from top researchers in related subjects.References
Deshmukh SP, Gonsalves CF, Guglielmo FF et al (2012) Role of MR imaging of uterine leiomyomas before and after embolization. Radiographics 32:E251–E281
Gambadauro P (2012) Dealing with uterine fibroids in reproductive medicine. J Obstet Gynaecol 32:210–216
Marret H, Fritel X, Ouldamer L et al (2012) Therapeutic management of uterine fibroid tumors: updated French guidelines. Eur J Obstet Gynecol Reprod Biol 165:156–164
Gorny KR, Woodrum DA, Brown DL et al (2011) Magnetic resonance-guided focused ultrasound of uterine leiomyomas: review of a 12-month outcome of 130 clinical patients. J Vasc Interv Radiol 22:857–864
Wu TI, Yen TC, Lai CH (2011) Clinical presentation and diagnosis of uterine sarcoma, including imaging. Best Pract Res Clin Obstet Gynaecol 25:681–689
Van den Bosch T, Coosemans A, Morina M et al (2012) Screening for uterine tumours. Best Pract Res Clin Obstet Gynaecol 26:257–266
Sahdev A, Sohaib SA, Jacobs I et al (2001) MR imaging of uterine sarcomas. AJR Am J Roentgenol 177:1307–1311
Ueda H, Togashi K, Konishi I et al (1999) Unusual appearances of uterine leiomyomas: MR imaging findings and their histopathologic backgrounds. Radiographics 19 Spec No: S131-S145
Tamai K, Koyama T, Saga T et al (2008) The utility of diffusion-weighted MR imaging for differentiating uterine sarcomas from benign leiomyomas. Eur Radiol 18:723–730
Namimoto T, Yamashita Y, Awai K et al (2009) Combined use of T2-weighted and diffusion-weighted 3-T MR imaging for differentiating uterine sarcomas from benign leiomyomas. Eur Radiol 19:2756–2764
Thomassin-Naggara I, Cuenod CA, Darai E et al (2008) Dynamic contrast-enhanced MR imaging of ovarian neoplasms: current status and future perspectives. Magn Reson Imaging Clin N Am 16:661–72, ix
James KE, White RF, Kraemer HC (2005) Repeated split sample validation to assess logistic regression and recursive partitioning: an application to the prediction of cognitive impairment. Stat Med 24:3019–3035
Thomassin-Naggara I, Darai E, Cuenod CA et al (2009) Contribution of diffusion-weighted MR imaging for predicting benignity of complex adnexal masses. Eur Radiol 19:1544–1552
Murase E, Siegelman ES, Outwater EK et al (1999) Uterine leiomyomas: histopathologic features, MR imaging findings, differential diagnosis, and treatment. Radiographics 19:1179–1197
Pelage JP, Cazejust J, Pluot E et al (2005) Uterine fibroid vascularization and clinical relevance to uterine fibroid embolization. Radiographics 25:S99–S117
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Thomassin-Naggara, I., Dechoux, S., Bonneau, C. et al. How to differentiate benign from malignant myometrial tumours using MR imaging. Eur Radiol 23, 2306–2314 (2013). https://doi.org/10.1007/s00330-013-2819-9
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00330-013-2819-9